Celanese Corp
For the period ended Nov 2, 2026. Filed Nov 2, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 2, 2026 · Filed Nov 2, 2026
Contents
EX-99.2 · Certain Items - Unaudited
Certain Items - Unaudited
The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures:
| Q3 '26 · Q2 '26 · Q1 '26 · 2025 · Q4 '25 · Q3 '25 · Q2 '25 · Q1 '25 · Income Statement Classification | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (In $ millions) | |||||||||||
| Exit and shutdown costs | 87 | 121 | 44 | 98 | 29 | 10 | 27 | 32 | Cost of sales / SG&A / Other (charges) gains, net / Gain (loss) on disposition of businesses and assets, net / Equity in net earnings (loss) of affiliates / Research & development expenses | ||
| Asset impairments | — | — | — | 1,513 | 27 | (1) | 1,486 | (2) | — | — | Other (charges) gains, net |
| Impact from plant incidents and natural disasters | — | — | 11 | 3 | — | — | — | 3 | Cost of sales | ||
| Mergers, acquisitions and dispositions | 12 | 35 | 15 | 52 | 23 | 12 | 12 | 5 | Cost of sales / SG&A / Other income (expense), net / Gain (loss) on disposition of assets, net / Research & development expenses | ||
| Actuarial (gain) loss on pension and postretirement plans | — | — | — | (49) | (49) | — | — | — | Cost of sales / SG&A / Non-operating pension and other postretirement employee benefit (expense) income | ||
| Legal settlements and commercial disputes | 10 | 4 | 3 | 17 | 1 | 11 | 2 | 3 | SG&A | ||
| (Gain) loss on disposition of businesses and assets | — | (4) | (50) | — | — | — | — | — | Gain (loss) on disposition of businesses and assets, net | ||
| Other | — | — | — | 5 | 3 | 1 | 1 | — | Cost of sales | ||
| Certain Items attributable to Celanese Corporation | 109 | 156 | 23 | 1,639 | 34 | 1,520 | 42 | 43 | |||
(1)Related to impairment of certain long-lived assets arising from unused parcels of property subsequently sold.
(2)Related to impairment of goodwill and certain trade names, primarily Zytel®, arising from our annual goodwill and indefinite-lived intangible assets impairment tests.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.